Single-centre follow-up of the PREMILOC trial in 52 children born extremely preterm (median age 11.7 years): early hydrocortisone vs placebo was not associated with different pulse wave velocity (median 4.84 vs 5.00 m/s; p=0.969), heart rate variability or blood pressure.
RCTn = 52
Benzouid et al. Hydrocortisone administration in preterm infants is not associated with adverse cardiovascular outcomes in childhood